A new AI for 5 million doctors in China: exclusive journal partnership focuses on evidence sources

中国500万医生的新AI：顶刊独家联手，卷的就是证据源

Alibaba Health launched the medical AI product Qinglizi for China’s 5 million doctors, with access to ten years of content from 70 BMJ Group journals and an evidence workflow constrained by PICO, GRADE, and review from more than 300 clinical experts.

Why it matters: HKR-H/K/R all pass: Alibaba Health and BMJ add concrete evidence sources and review mechanisms to a medical AI product. It remains a vertical product/partnership update, not a foundation-model or platform release.